Pareja-Ríos Alicia, Bonaque-González Sergio
Department of Ophthalmology, University Hospital of the Canary Islands, Santa Cruz de Tenerife, Spain.
Wooptix S.L, Santa Cruz de Tenerife, Spain.
Arq Bras Oftalmol. 2020 Jan-Feb;83(1):73-75. doi: 10.5935/0004-2749.20200013.
We describe three patients who had previous heart diseases and nonproliferative diabetic retinopathy with clinically significant diabetic macular edema. They underwent unilateral dexamethasone intravitreal implantation. Without ophthalmological treatment in the fellow eye, patients showed marked bilateral improvement in best-corrected visual acuity, optical coherence images, and macular thickness values. These findings provide evidence of the bilateral effect of dexamethasone intravitreal implantation, which may be clinically useful in patients for whom the systemic effects of the drug may affect their general health.
我们描述了三名患有既往心脏病和非增殖性糖尿病视网膜病变且伴有具有临床意义的糖尿病性黄斑水肿的患者。他们接受了单侧玻璃体内地塞米松植入术。在未对另一只眼进行眼科治疗的情况下,患者的最佳矫正视力、光学相干图像和黄斑厚度值均出现了明显的双侧改善。这些发现为玻璃体内地塞米松植入术的双侧效应提供了证据,这对于那些药物的全身效应可能影响其总体健康的患者在临床上可能是有用的。